PYC
PYC THERAPEUTICS LIMITED
$2.14
▼ -10.46%
Market cap
$2.10B
Turnover
$11,108,437
Last price
$2.14
Day change
-10.46%
Announcements
10
Range, past year
Open 1.150 · Low 0.847 · Now 2.140 · High 2.930
Open PYC in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
PYC momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
55/100
Wyckoff phase
Accumulation1d
Trend stage
Neutral
1 Day
-10.5%
1 Week
-20.1%
1 Month
-4.0%
1 Year
+91.1%
RSI
37
Avg daily range
7.4%
PYC THERAPEUTICS LIMITED scores 55 out of 100 for momentum quality, a reading rated medium confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 1 trading day. The weekly timeframe reads Uptrend, which does not yet agree with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads moderate.
Points to watch
- 60d drawdown -26.5%
- High volatility (ATR 7.4%)
- Risk rating: Very High
- Composite downside risk elevated
PYC announcements
Recent price-sensitive releases.
- 2026-10-07 PKD Program - Presentation of Data at ASN Conference Progress Report
- 2026-08-28 Appendix 4E Preliminary Final Report
- 2026-07-29 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-07-22 PKD - Safety Committee Approves Dose Escalation
- 2026-07-21 ADOA Program Update
- 2026-05-07 PKD - Initiation of Multiple Dose Clinical Trial
- 2026-05-04 Presentation of Ophthalmology Clinical Trial Data at ARVO
More Health Care stocks
Most traded in the same sector.